SMOGOOO SCIENCEBETTER MEDICINEESMOBEST PRACTICE0PENSPECAL ARTICLEPrognostic evaluation in patients with advanced cancer in the last months oflife:ESMO Clinical Practice GuidelineP.StoneP.Buckle R.DolanJ.Feliu D.Huis,B.J.A.Laird,M.Maltoni1 S.Moine2,T.Morita,M.Nabal4V.Vickerstaff15,N.White,D.Santini15 CI.Ripamonti1,on behalf of the ESMO Guidelines Committee'Marie Curie Palliative Care Research Department,Division of Psychiatry,University College London,London;Palliative Care Team,Central and North West LondonNHS Trust,London;3Marie Curie Charity,London;Academic Unit of Surgery,University of Glasgow,Glasgow Royal Infirmary,Glasgow,UK;5Department of MedicalOncology,La Paz University Hospital,IdiPAZ,CIBERONC,Catedra UAM-AMGEN,Madrid,Spain;Departments of Palliative Care,Rehabilitation and IntegrativeMedicine;General Oncology,University of Texas MD Anderson Cancer Center,Houston,USA;Institute of Genetics and Cancer,University of Edinburgh,WestemGeneral Hospital,Edinburgh;t Columba's Hospice Care,Edinburgh,UK:Medical Oncology Unit,IRCCS Azienda Ospedaliero-Universitaria di Bologna,Bologna;Department of Specialised,Experimental and Diagnostic Medicine,University of Bologna,Bologna,ltaly;Health Education and PracticesLaboratory (LEPS EA3412)University Paris Sorbonne Paris Cite,Bobigny,Paris,France;Department of Palliative and Supportive Care,Palliative Care Team and Seirei Hospice,Seirei MikataharaGeneral Hospital,Shizuoka,Japan;Palliative Care Supportive Team,Hospital Universitario Amau de Vilanova,Lleida,Spain;Research Department of Primary Careand Population Health,University College London,London,UK;UOC Oncologia Medica Territoriale,La Sapienza University of Rome,Polo Pontino,Rome;Department of Medical and Surgical Specialties,Radiological Sciences and Public Health,University of Brescia,Brescia,ItalyAvailable online 11 April 2023Key words:advanced cancer,ESMO Clinical Practice Guideline,palliative care,prognostic factors,risk predictionmodelsINTRODUCTIONprovide opportunities for patients and their families toPatients with cancer may have potentially curable diseasefocus on the things that are most important to them whenor may live for many years despite incurable cancer.How-time is short.Prognostic information can also facilitate ac-ever,these guidelines specifically relate to patients withcess to services and benefits.At an organisational level,advanced incurable cancer who are expected to live for aprognoses can be helpful for describing the case mix offew months or less.Distinction is made between patientsservices or for summarising the health status of patients inwith a few months to live,who may or may not be receivingdifferent arms of a clinical trial.At an individual level,anticancer therapies,and those thought to be imminentlyprognoses can provide information about when a particulardying (i.e.within days or weeks).This guideline focuses onpatient is likely to die.the prediction of death or length of survival and not otherclinically-important o
